Lacouture, M E <br/><br/>
Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor.  [electronic resource] 

 -  Clinical and experimental dermatology  Nov 2006 
 - 783-5 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0307-6938 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2230.2006.02223.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Benzenesulfonates--adverse effects<br/>Drug Eruptions--etiology<br/>Humans<br/>Keratosis--chemically induced<br/>Male<br/>Middle Aged<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Photosensitivity Disorders--chemically induced<br/>Protein Kinase Inhibitors--adverse effects<br/>Pyridines--adverse effects<br/>Sorafenib